People | December 09, 2022
Lupin appoints Spiro Gavaris as President of U.S. Generics Business
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Valorum will advance the commercialization and distribution of Armlupeg in the United States
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Subscribe To Our Newsletter & Stay Updated
